Allscripts Healthcare Solutions (NASDAQ:MDRX) issued its earnings results on Thursday. The software maker reported $0.18 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.08 by $0.10, MarketWatch Earnings reports. Allscripts Healthcare Solutions had a positive return on equity of 5.52% and a negative net margin of 3.06%. The company had revenue of $406.20 million during the quarter, compared to the consensus estimate of $399.80 million.
NASDAQ MDRX traded up $1.41 during midday trading on Friday, hitting $9.00. The company had a trading volume of 7,277,317 shares, compared to its average volume of 1,111,904. Allscripts Healthcare Solutions has a twelve month low of $4.56 and a twelve month high of $11.82. The firm has a 50-day moving average price of $6.77 and a 200-day moving average price of $7.16. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $1.46 billion, a PE ratio of -27.27, a P/E/G ratio of 3.03 and a beta of 0.98.
Several brokerages have recently commented on MDRX. Morgan Stanley lifted their target price on Allscripts Healthcare Solutions from $5.00 to $6.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Goldman Sachs Group cut Allscripts Healthcare Solutions from a “neutral” rating to a “sell” rating and dropped their price target for the stock from $6.50 to $5.50 in a report on Tuesday, July 21st. BidaskClub raised Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Tuesday, July 21st. Deutsche Bank dropped their price target on Allscripts Healthcare Solutions from $11.00 to $9.00 and set a “hold” rating for the company in a report on Thursday, June 11th. Finally, SVB Leerink lifted their price target on Allscripts Healthcare Solutions from $6.00 to $10.00 and gave the stock a “market perform” rating in a report on Friday. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have given a buy rating to the stock. Allscripts Healthcare Solutions has a consensus rating of “Hold” and a consensus price target of $8.93.
In other news, insider Lisa Khorey sold 30,000 shares of Allscripts Healthcare Solutions stock in a transaction on Friday, June 5th. The stock was sold at an average price of $7.06, for a total value of $211,800.00. Following the transaction, the insider now owns 285,889 shares in the company, valued at approximately $2,018,376.34. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 1.42% of the company’s stock.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.
Further Reading: What are the benefits of a balanced fund?
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.